- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00728377
An Exercise Intervention to Prevent Gestational Diabetes
October 24, 2016 updated by: Lisa Chasan-Taber, University of Massachusetts, Amherst
An Exercise Intervention to Prevent Recurrent GDM
Women diagnosed with gestational diabetes mellitus (GDM) are at substantially increased risk of developing type 2 diabetes and obesity, currently at epidemic rates in the United States.
GDM, therefore, identifies a population of women at high risk of developing type 2 diabetes and thus provides an excellent opportunity to intervene years before the development of this disorder.
It is well recognized that acute as well as chronic physical activity reduce fasting plasma glucose as well as improve glucose tolerance in type 2 diabetes.
Recent studies have suggested that women with higher levels of physical activity have reduced risk of GDM.
Therefore, we will test the hypothesis that an exercise intervention is an effective tool for preventing GDM among women with a history of GDM.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary goals of the application are to investigate the effects of a motivationally-tailored, individually targeted 12-wk physical activity intervention on 1) risk of GDM in women at high risk of the condition, 2) serum biomarkers associated with insulin resistance, 3) and the adoption and maintenance of exercise during pregnancy.
Secondary goals are to investigate the impact of the intervention on gestational weight gain and selected birth outcomes.
The overall goal of the intervention is to encourage pregnant women to achieve the American College of Obstetricians and Gynecologists (ACOG) Guidelines for physical activity during pregnancy (30 minutes or more of moderate- intensity activity on most days of the week) through increasing walking and developing a more active lifestyle.
The intervention draws from the theory of Stages of Motivational Readiness for Change and Social Cognitive Theory constructs for physical activity behavior and will take into account the specific social, cultural, economic, and physical environmental challenges faced by women of diverse socioeconomic and ethnic backgrounds.
The application is innovative in being the first, to our knowledge, to test a physical activity intervention designed to prevent GDM among high risk women.
The intervention protocol can readily be translated into clinical practice in underserved and minority populations.
Study Type
Interventional
Enrollment (Actual)
488
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Springfield, Massachusetts, United States, 01199
- Batstate Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- history of gestational diabetes or overweight (>25 kg/m2) with family history of type 2 diabetes
- sedentary
Exclusion Criteria:
- history of diagnosis of diabetes, hypertension, heart disease or chronic renal disease
- current medications which adversely influence glucose tolerance
- not planning to continue the pregnancy to term
- >16 weeks gestation
- contraindications to participating in moderate physical activity
- inability to read English at a 6th grade level
- self-reported participation in >30 min of moderate or vigorous-intensity exercise on >3 days/wk
- prior participation in the study
- non-singleton pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise
|
Individually Tailored (IT) Exercise Intervention This intervention is designed to increase the amount of physical activity incorporated into the daily lifestyle of pregnant women, primarily through increased walking, with the ultimate goal of achieving the American College of Obstetricians and Gynecologists (ACOG) exercise goals for pregnant women.
These goals are the same as the Surgeon General's Guidelines for physical activity for nonpregnant individuals (30 minutes or more or moderate activity on most days of the week).The intervention includes: 1) individually tailored print-based materials (i.e., individually-tailored reports and stage-matched manuals), 2) self-monitoring materials, and 3) goal setting.
|
Active Comparator: Heath & Wellness
|
The comparison intervention consists of a series of informational booklets published by the American College of Obstetricians and Gynecologists on general issues related to health and wellness during pregnancy.
These include alcohol and drug use during pregnancy, easing back pain, as well as the Pregnancy Fitness brochure on the safety of exercise during pregnancy.
These booklets are selected to represent high-quality, standard, low-cost, self-help material currently available to the public.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Gestational diabetes diagnosis assessed through glucose tolerance test.
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Maternal weight gain
Time Frame: 40 weeks gestational age
|
40 weeks gestational age
|
Glucose
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
Insulin
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
Adiponectin
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
Resistin
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
TNF-alpha
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
CRP
Time Frame: 28 weeks gestational age
|
28 weeks gestational age
|
Birth weight
Time Frame: 40 weeks gestational age
|
40 weeks gestational age
|
Apgar score
Time Frame: 40 weeks gestational age
|
40 weeks gestational age
|
Adoption and maintenance of exercise during pregnancy
Time Frame: 40 weeks gestational age
|
40 weeks gestational age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lisa Chasan-Taber, University of Massachusetts, Amherst
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hawkins M, Chasan-Taber L, Marcus B, Stanek E, Braun B, Ciccolo J, Markenson G. Impact of an exercise intervention on physical activity during pregnancy: the behaviors affecting baby and you study. Am J Public Health. 2014 Oct;104(10):e74-81. doi: 10.2105/AJPH.2014.302072. Epub 2014 Aug 14.
- Hawkins M, Braun B, Marcus BH, Stanek E 3rd, Markenson G, Chasan-Taber L. The impact of an exercise intervention on C - reactive protein during pregnancy: a randomized controlled trial. BMC Pregnancy Childbirth. 2015 Jun 24;15:139. doi: 10.1186/s12884-015-0576-2.
- Nobles C, Marcus BH, Stanek EJ 3rd, Braun B, Whitcomb BW, Solomon CG, Manson JE, Markenson G, Chasan-Taber L. Effect of an exercise intervention on gestational diabetes mellitus: a randomized controlled trial. Obstet Gynecol. 2015 May;125(5):1195-1204. doi: 10.1097/AOG.0000000000000738.
- Chasan-Taber L, Silveira M, Marcus BH, Braun B, Stanek E, Markenson G. Feasibility and efficacy of a physical activity intervention among pregnant women: the behaviors affecting baby and you (B.A.B.Y.) study. J Phys Act Health. 2011 Sep;8 Suppl 2(0 2):S228-38.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2007
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
August 2, 2008
First Submitted That Met QC Criteria
August 2, 2008
First Posted (Estimate)
August 5, 2008
Study Record Updates
Last Update Posted (Estimate)
October 26, 2016
Last Update Submitted That Met QC Criteria
October 24, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DK74876
- R01DK074876 (U.S. NIH Grant/Contract)
- 1R01DK074876-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
Royal College of Surgeons, IrelandHealth Research Board, IrelandUnknownPre-Gestational Diabetes
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
Baylor College of MedicineRecruitingGestational Diabetes MellitusUnited States
-
Joslin Diabetes CenterRoche DiagnosticsCompletedGestational Diabetes MellitusUnited States
-
Ludwig-Maximilians - University of MunichGerman Federal Ministry of Education and Research; Helmholtz Zentrum MünchenCompletedGestational Diabetes MellitusGermany
Clinical Trials on Heath & Wellness
-
Yale UniversitySubstance Abuse and Mental Health Services Administration (SAMHSA)CompletedHiv | Pre-Exposure Prophylaxis | MenUnited States
-
Aga Khan UniversityImperial College London; Wellcome TrustUnknownHypertension | Obesity | Cardiovascular Disease | Diabetes | Kidney DiseasePakistan
-
University of Texas at AustinCompleted
-
University of Texas at AustinCompletedHealthy | Chronic Pain | Stress, PsychologicalUnited States
-
Mayo ClinicCompletedInflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisUnited States
-
Bournemouth UniversityRoyal Bournemouth and Christchurch Hospitals NHS Foundation Trust; Oomph! Wellness and other collaboratorsWithdrawnFrail Elderly Syndrome | Frailty | Sedentary Behavior | Life Style Induced Illness | Lifestyle, Sedentary
-
University of Texas at AustinCompletedHealthy | Rheumatoid Arthritis | Chronic Pain | Stress | PsychologicalUnited States
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedObesity | SchizophreniaBrazil
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruiting